Accessibility Menu
 
enVVeno Medical logo

enVVeno Medical

(NASDAQ) NVNO

Current Price$10.14
Market Cap$6.64M
Since IPO (2018)-100%
5 Year-96%
1 Year-89%
1 Month+1%

enVVeno Medical Financials at a Glance

Market Cap

$6.64M

Revenue (TTM)

$0.00

Net Income (TTM)

$19.47M

EPS (TTM)

$-33.05

P/E Ratio

-0.31

Dividend

$0.00

Beta (Volatility)

1.12 (Average)

Price

$10.14

Volume

637

Open

$10.14

Previous Close

$10.14

Daily Range

$10.14 - $10.14

52-Week Range

$8.67 - $196.70

NVNO News

No articles available.

NVNO: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About enVVeno Medical

Industry

Healthcare Equipment and Supplies

Employees

33

CEO

Robert Andrew Berman

Headquarters

Irvine, CA 92618, US

NVNO Financials

Key Financial Metrics (TTM)

Gross Margin

0%

Operating Margin

0%

Net Income Margin

0%

Return on Equity

-56%

Return on Capital

-76%

Return on Assets

-66%

Earnings Yield

-3.23%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$6.64M

Shares Outstanding

655.50K

Volume

637

Short Interest

0.00%

Avg. Volume

21.59K

Financials (TTM)

Gross Profit

$489.00K

Operating Income

$20.90M

EBITDA

$20.41M

Operating Cash Flow

$15.57M

Capital Expenditure

$5.00K

Free Cash Flow

$15.57M

Cash & ST Invst.

$28.21M

Total Debt

$700.00K

enVVeno Medical Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$0.00

N/A

Gross Profit

$117.00K

+4.1%

Gross Margin

0.00%

N/A

Market Cap

$6.64M

N/A

Market Cap/Employee

$179.47K

N/A

Employees

37

N/A

Net Income

$3.74M

+40.0%

EBITDA

$5.05M

+17.4%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$27.51M

-34.6%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$310.00K

-55.7%

Short Term Debt

$390.00K

+7.1%

Return on Assets

-65.87%

N/A

Return on Invested Capital

-76.16%

N/A

Free Cash Flow

$3.44M

+32.6%

Operating Cash Flow

$3.44M

+32.6%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
VVOSVivos Therapeutics, Inc.
$1.18+8.26%
ALURAllurion Technologies Inc.
$0.68+4.57%
CODXCo-Diagnostics, Inc.
$1.86+9.41%
AEMDAethlon Medical, Inc.
$2.19+3.79%

Trending Stocks

Symbol / CompanyPricePrice Chg
NVDANvidia
$174.40+0.06%
TQQQProShares Trust - ProShares UltraPro Qqq
$41.68+0.10%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$7.55-0.11%
QQQInvesco QQQ Trust
$577.18+0.03%

Questions About NVNO

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.